Non-Alcoholic Steatohepatitis Pathogenesis: Role of Repair in Regulating the Disease Progression

被引:24
|
作者
Jung, Youngmi [1 ]
Diehl, Anna Mae [1 ]
机构
[1] Duke Univ, Div Gastroenterol, Durham, NC 27710 USA
关键词
Apoptosis; Liver regeneration; Fibrogenesis; Progenitors; Hedgehog; FATTY LIVER-DISEASE; IKK-BETA; HEDGEHOG; ACTIVATION; APOPTOSIS; VIABILITY; CELLS;
D O I
10.1159/000282092
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background: Increased hepatocyte apoptosis distinguishes non-alcoholic steatohepatitis (NASH) from non-alcoholic fatty liver disease (NAFLD). Therefore, we postulated that outcomes of NASH depended upon whether or not hepatic regenerative responses could keep pace with the increased rate of hepatocyte death. Methods: To investigate mechanisms that the liver deploys to compensate for increased hepatocyte apoptosis, we studied a transgenic mouse model in which hepatocyte vulnerability to apoptosis was increased due to disruption of NF-kappa B survival signaling. Results: We learned that hepatocyte death is coupled to the expansion of cell types that are involved in liver repair, including progenitors and myofibroblasts, and discovered that the outgrowth of these cell types occurs, at least in part, because dying hepatocytes produce Hedgehog morphogens that enhance the growth of progenitor and myofibroblast populations. The clinical significance of this discovery is supported by evidence that the degree of Hedgehog pathway activation also parallels the severity of liver fibrosis in patients with NASH, a disease in which hepatocyte apoptotic activity has been strongly linked to fibrosis progression. Conclusion: The data generated by studying a mouse model of chronic hepatocyte apoptosis, as well as NASH, a common human liver disease that is characterized by increased rates of hepatocyte apoptosis, are very similar. Both strongly support the concept that repair responses play an important role in controlling the outcomes of NASH. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:225 / 228
页数:4
相关论文
共 50 条
  • [11] Apoptosis and Cytokinesin Non-Alcoholic Steatohepatitis
    Syn, Wing-Kin
    Choi, Steve S.
    Diehl, Anna Mae
    CLINICS IN LIVER DISEASE, 2009, 13 (04) : 565 - +
  • [12] Role of Selenoprotein W in participating in the progression of non-alcoholic fatty liver disease
    Miao, Zhiruo
    Wang, Wei
    Miao, Zhiying
    Cao, Qiyuan
    Xu, Shiwen
    REDOX BIOLOGY, 2024, 71
  • [13] Pathogenesis and novel treatment options for non-alcoholic steatohepatitis
    Wong, Vincent Wai-Sun
    Chitturi, Shiv
    Wong, Grace Lai-Hung
    Yu, Jun
    Chan, Henry Lik-Yuen
    Farrell, Geoffrey C.
    LANCET GASTROENTEROLOGY & HEPATOLOGY, 2016, 1 (01) : 56 - 67
  • [14] Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis
    Bellanti, Francesco
    Villani, Rosanna
    Facciorusso, Antonio
    Vendemiale, Gianluigi
    Serviddio, Gaetano
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 111 : 173 - 185
  • [15] Pathogenesis and treatment of non-alcoholic steatohepatitis and its fibrosis
    Lee, Kuei-Chua
    Wu, Pei-Shan
    Lin, Han-Chieh
    CLINICAL AND MOLECULAR HEPATOLOGY, 2023, 29 (01) : 77 - 98
  • [16] Alcoholic and non-alcoholic steatohepatitis
    Neuman, Manuela G.
    French, Samuel W.
    French, Barbara A.
    Seitz, Helmut K.
    Cohen, Lawrence B.
    Mueller, Sebastian
    Osna, Natalia A.
    Kharbanda, Kusum K.
    Seth, Devanshi
    Bautista, Abraham
    Thompson, Kyle J.
    McKillop, Iain H.
    Kirpich, Irina A.
    McClain, Craig J.
    Bataller, Ramon
    Nanau, Radu M.
    Voiculescu, Mihai
    Opris, Mihai
    Shen, Hong
    Tillman, Brittany
    Li, Jun
    Liu, Hui
    Thomes, Paul G.
    Ganesan, Murali
    Malnick, Steve
    EXPERIMENTAL AND MOLECULAR PATHOLOGY, 2014, 97 (03) : 492 - 510
  • [17] Natural Progression of Non-Alcoholic Steatohepatitis to Hepatocellular Carcinoma
    Ramai, Daryl
    Tai, Waqqas
    Rivera, Michelle
    Facciorusso, Antonio
    Tartaglia, Nicola
    Pacilli, Mario
    Ambrosi, Antonio
    Cotsoglou, Christian
    Sacco, Rodolfo
    BIOMEDICINES, 2021, 9 (02) : 1 - 17
  • [18] Future trends in the treatment of non-alcoholic steatohepatitis
    Fiorucci, Stefano
    Biagioli, Michele
    Distrutti, Eleonora
    PHARMACOLOGICAL RESEARCH, 2018, 134 : 289 - 298
  • [19] Role of microRNA in non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH): a comprehensive review
    Changez, Mah I. Kan
    Mubeen, Maryam
    Zehra, Monezahe
    Samnani, Inara
    Rasool, Aniqa Abdul
    Mohan, Anmol
    Ul Wara, Um
    Tejwaney, Usha
    Kumar, Vikash
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2023, 51 (09)
  • [20] The role of oxidative stress in non-alcoholic steatohepatitis
    Koek, G. H.
    Liedorp, P. R.
    Bast, A.
    CLINICA CHIMICA ACTA, 2011, 412 (15-16) : 1297 - 1305